DNA — Ginkgo Bioworks Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapSucker Stock

Annual balance sheet for Ginkgo Bioworks Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	495	381	1,550	1,316	944
Net Total Accounts Receivable
Net Total Receivables	8.78	24.2	150	84	31.7
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	512	427	1,723	1,450	1,002
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	63.1	121	146	716	397
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	697	675	2,071	2,539	1,665
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	40.1	73.2	135	173	164
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	204	214	566	803	568
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	493	461	1,505	1,736	1,097
Total Liabilities & Shareholders' Equity	697	675	2,071	2,539	1,665
Total Common Shares Outstanding